Standard Biotools (LAB) Long-Term Debt Repayments (2011 - 2024)
Standard Biotools (LAB) reported Long-Term Debt Repayments of $55.0 million for Q4 2024, up 4300.0% year-over-year from $1.2 million in Q1 2024, and up 571.39% on a QoQ basis from $8.2 million in Q1 2024.
Standard Biotools (LAB) has 6 years of Long-Term Debt Repayments data on file, last reported at $55.0 million in Q4 2024.
- Quarterly Long-Term Debt Repayments rose 4300.0% year-over-year to $55.0 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $55.0 million (up 482.5% YoY) and the FY2024 annual result came in at $63.2 million, up 2933.7% from the prior year.
- Long-Term Debt Repayments climbed to $55.0 million in Q4 2024 per LAB's latest filing, from $8.2 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $55.0 million in Q4 2024 and bottomed at $501000.0 in Q1 2021.
- The 4-year median for Long-Term Debt Repayments is $1.0 million (2023), against an average of $9.2 million.
- The widest annual swing landed in 2022, when Long-Term Debt Repayments surged 1264.87%; it then soared 4300.0% in 2024.
- Tracing LAB's Long-Term Debt Repayments over 4 years: stood at $501000.0 in 2021, then surged by 1264.87% to $6.8 million in 2022, then tumbled by 81.72% to $1.2 million in 2023, then soared by 4300.0% to $55.0 million in 2024.
- Per Business Quant, the three latest LAB Long-Term Debt Repayments figures stand at $55.0 million (Q4 2024), $8.2 million (Q1 2024), and $1.2 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 55.00 Mn |
| Dec 31, 2024 | 55.00 Mn |
| Mar 31, 2024 | 8.19 Mn |
| Mar 31, 2024 | 8.19 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 833,000.00 |
| Sep 30, 2023 | 833,000.00 |
| Mar 31, 2022 | 6.84 Mn |
| Mar 31, 2022 | 6.84 Mn |
| Sep 30, 2021 | 501,000.00 |
| Sep 30, 2021 | 501,000.00 |
| Jun 30, 2021 | 501,000.00 |
| Jun 30, 2021 | 501,000.00 |
| Mar 31, 2021 | 501,000.00 |
| Mar 31, 2021 | 501,000.00 |
| Dec 31, 2012 | -8.32 Mn |
| Dec 31, 2012 | -8.32 Mn |
| Sep 30, 2012 | 2.84 Mn |
| Sep 30, 2012 | 2.84 Mn |
| Jun 30, 2012 | 1.90 Mn |
| Jun 30, 2012 | 1.90 Mn |
| Mar 31, 2012 | 3.82 Mn |
| Mar 31, 2012 | 3.82 Mn |
| Dec 31, 2011 | -140,000.00 |
| Dec 31, 2011 | -140,000.00 |
| Sep 30, 2011 | 1.43 Mn |
| Sep 30, 2011 | 1.43 Mn |
| Jun 30, 2011 | 1.38 Mn |
| Jun 30, 2011 | 1.38 Mn |
| Mar 31, 2011 | 447,000.00 |
| Mar 31, 2011 | 447,000.00 |